Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

In order to diagnose a patient with multiple myeloma, a physician will typically order several different tests. That’s because multiple myeloma is a complex disease and knowing the results of these ...

Chronic lymphocytic leukemia (CLL) is a form of cancer that leads to an atypically high level of lymphocytes within the bone marrow. Tests, such as a bone marrow biopsy, can determine how advanced CLL ...

Atypical clustering of myeloid progenitor cells called "myeloblasts" (white arrows), defined by their co-expression of CD34 (magenta) and CD117 (green), in a bone marrow biopsy tissue from a patient ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...